Hypofractionated Radiotherapy plus Cetuximab in Locally Advanced Head and Neck Cancer

被引：7

作者：

Teoh, D. C. ^{[1
]}

Rodger, S. ^{[2
]}

Say, J. ^{[2
]}

Hartley, A. ^{[1
]}

机构：

[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England

[2] Univ Birmingham, Fac Med, Birmingham, W Midlands, England

来源：

CLINICAL ONCOLOGY | 2008年 / 20卷 / 09期

关键词：

D O I：

10.1016/j.clon.2008.07.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：717 / 717

页数：1

共 4 条

[1] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].

Bonner, JA ;

Harari, PM ;

Giralt, J ;

Azarnia, N ;

Shin, DM ;

Cohen, RB ;

Jones, CU ;

Sur, R ;

Raben, D ;

Jassem, J ;

Ove, R ;

Kies, MS ;

Baselga, J ;

Youssoufian, H ;

Amellal, N ;

Rowinsky, EK ;

Ang, KK .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578

[2] Cetuximab is effective, but more toxic than reported in the bonner trial [J].

Lord, H. K. ;

Junor, E. ;

Ironside, J. .

CLINICAL ONCOLOGY, 2008, 20 (01) :96-96

[3] Carboplatin and hypofractionated accelerated radiotherapy: A dose escalation study of an outpatient chemoradiation schedule for squamous cell carcinoma of the head and neck [J].

Madhava, K ;

Hartley, A ;

Wake, M ;

Watkinson, JC ;

Glaholm, J .

CLINICAL ONCOLOGY, 2006, 18 (01) :77-81

[4] Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:: three meta-analyses of updated individual data [J].

Pignon, JP ;

Bourhis, J ;

Domenge, C ;

Designé, L .

LANCET, 2000, 355 (9208) :949-955

← 1 →